You are here

ImmunityBio

ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo

Clinical Trials Arena

Thu, 01/30/25 - 10:52 am

clinical trials

advanced non-small cell lung cancer

metastatic non-small cell lung cancer

Fresh off first regulatory win, ImmunityBio hints at financial troubles

First Word Pharma

Fri, 09/6/24 - 11:13 am

As rival Merck monopolizes BCG supply, ImmunityBio taps Serum Institute for new combo's manufacturing

Fierce Pharma

Mon, 05/6/24 - 11:30 am

ImmunityBio bags FDA approval for Anktiva to challenge Merck in bladder cancer

Fierce Pharma

Tue, 04/23/24 - 10:32 am

Patrick Soon-Shiong

After FDA rejection, ImmunityBio lays off staff in California and Florida

Fierce Biotech

Mon, 09/25/23 - 10:11 am

Immunitybio slumps as FDA declines to approve bladder cancer treatment

NASDAQ

Thu, 05/11/23 - 09:58 am

ImmunityBio’s Bladder Cancer Immunotherapy BLA gets FDA Nod

BioSpace

Mon, 08/1/22 - 10:29 am

ImmunityBio’s Patrick Soon-Shiong Discusses Quest to Orchestrate NK and T Cells

BioSpace

Thu, 06/16/22 - 10:21 am

Pantrick Soon-Shiong

Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech

Pharmaforum

Wed, 01/13/21 - 12:08 am

ImmunityBio, NantKwest announce positive interim phase 1 safety data of hAd5 Covid-19 vaccine dose study

Pharmaceutical Business Review

Wed, 11/11/20 - 11:06 am

clinical trials

The Inside Story Of Biotech’s Barnum And His Covid Cures

Forbes

Thu, 08/27/20 - 12:39 pm

Patrick Soon-Shiong

ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials

BioSpace

Thu, 05/21/20 - 11:11 pm

clinical trials